Molecule Holdings Overview
Get informed when a big investor buys or sells
+ Follow68.00%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for MLCL.CN is 68.0%. That is above the sector sector average of 11.85%. Investors often review this figure alongside Molecule Holdings's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, MLCL.CN currently prints 68.0% for ROE, while the sector average sits near 11.85%. That is roughly 473.7% above the sector mean. Large gaps often invite a closer look at Molecule Holdings's growth, margins, and balance sheet.
Return on Equity shows how effectively Molecule Holdings converts resources into returns. At 68.0%, MLCL.CN may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MLCL.CN's ROE (68.0%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
